Onco-Cardiology Consensus Paper of the German Cardiac Society, the German Society for Pediatric Cardiology and Congenital Heart Defects and the German Society for Hematology and Medical Oncology

Acute and chronic side effects of modern, multimodal treatment of advanced cancers significantly impact the quality of life and survival in patients with malignant diseases. The essential components of these treatment modalities include radiotherapy, classical (conventional) chemotherapy, immunotherapy and the so-called molecular targeted therapies. In addition to the established treatment strategies up to 30 newly approved drugs enter the market each year, with only incompletely characterized side effect profiles. This consensus paper addresses the risk factors for potential adverse reactions under tumor treatment and furthermore lists specific side effect profiles for the various treatment groups. Novel cancer therapies are discussed and recommendations for the treatment of specific patient groups are presented